Skip to content

Ivonne Esther Hernandez Castro, M.D.

NPI 1386136059ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Naranjito, PR

Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in Naranjito, Puerto Rico, licensed in PR, with an NPI issued in May 2018. Part D covered 103 prescriptions written in 2024, 51% of them generic. Boehringer Ingelheim Pharmaceuticals, Inc. was the largest of 19 companies reporting payments in 2025, $2,330 in all, mostly food and beverage.

Overview

NPI1386136059
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedMay 30, 2018
Last updated in NPPESAug 4, 2026
Certified by providerAug 4, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (PR)

Part D prescriptions in 2024

Prescriptions (claims)103 · 116 30-day fills
Patients21
Total drug cost$24,888
Generic share51% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$2,330 · 64 payments from 19 companies
  • 2024$1,520 · 46 payments from 18 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$2,238 · 63 payments
  • Travel and Lodging$92.72 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records